Answers are grounded in this paper and cite their sources.
Background: Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disorder characterized by joint pain, swelling, and stiffness. Its clinical manifestations are comparable to Uthiravatha Suronitham described in Siddha literature. This case report describes the clinical management of RA using Siddha internal medicines and selected external therapies. Case Presentation: A 42-year-old woman presented with multiple joint pain, swelling, morning stiffness, and restricted movements. Laboratory investigations showed positive anti-cyclic citrullinated peptide antibodies, elevated C-reactive protein, and negative rheumatoid factor. The patient received internal Siddha formulations, including Thirikadugu Chooranam, Arumuga Chenduram, and Seenthil Chooranam, together with selected external therapies, including Nasiyam and Peechu. Results: Following 51 days of treatment, the Rheumatoid Arthritis Pain Scale score decreased from 110 to 79, while the Visual Analogue Scale score decreased from 7 to 3. Morning stiffness decreased from approximately 45 minutes to 10 minutes. Improvements in joint pain, swelling, mobility, and daily activities were also observed. No significant adverse drug reactions were reported. Conclusion: This case demonstrates encouraging symptomatic improvement following a combined Siddha treatment regimen. Further controlled clinical studies are required to establish its safety, effectiveness, and therapeutic contribution to rheumatoid arthritis management.
No takes yet. Share an insight, caveat, or question.
Rajendran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: